Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGRABINS1: Exenatide effect on cerebral blood flow in non-stroke volunteers
NCT02838589Phase 2Completed
- Start
- Aug 2016
- Primary completion
- Feb 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of exenatide in stroke. Started Aug 2016; status: completed.
02
Drugs
exenatide
03
Conditions
stroke
Beyond the preview
Go deeper on NCT02838589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02838589.